Dose-Dependent Valproate-Induced Alopecia in Patients with Mental Disorders

    Takashi Tomita, Hidekazu Goto, Tadashi Yoshida … Yukinao Kohda
    Studysummary This study reports that alopecia may develop in patients with chronic exposure to high plasma concentrations of valproate, but resolved after dose reduction or treatment discontinuation.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on journals.lww.com →
    Discuss this study in the Community →

    Research cited in this study 4

    1. Serum Drug Level-Related Sodium Valproate-Induced Hair Loss Indian Journal of Pharmacology · 2013
    2. Hair Loss in Psychopharmacology Annals of clinical psychiatry · 2000
    3. Hair Loss in Psychopharmacology Annals of Clinical Psychiatry · 2000
    4. Alopecia and Mood Stabilizer Therapy Annals of Clinical Psychiatry · 1996

    Related research 5

    1. Sodium Valproate Induced Alopecia: A Case Series Journal of Clinical and Diagnostic Research · 2017
    2. Dose-Dependent Valproate-Induced Alopecia in Patients with Mental Disorders Indian Journal of Pharmacology/˜The œIndian journal of pharmacology · 2015
    3. Olanzapine Induced Hair Loss: A Case Report Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · 2012
    4. Valproic Acid (Depakene): A New Anticonvulsant Agent JAMA · 1978
    5. Valproic Acid (Depakene) JAMA · 1978